Spark Therapeutics Acquisition Sparks Rally in Biotechnology ETFs
This article was originally published on ETFTrends.com.
Biotechnology stocks and sector-specific ETFs climbed Monday after Roche (RHHBY) acquired gene therapy researcher Spark Therapeutics (ONCE). Among the best performing ETFs of Monday, the Invesco Dynamic Biotech & Genome ETF (NYSEArca: PBE) increased 5.4%, SPDR S&P Biotech ETF (NYSEArca: XBI) advanced 4.2% and ALPS Medical Breakthroughs ETF (NYSEArca: SBIO) gained 3.1%. The biotech ETFs [...]